All In Biotech

Free tool

FAERS Monitor: Yuflyma

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761219 or its brand name (Yuflyma, Adalimumab-Aaty). Reports on generic versions are filed under their own applications.

Reports

49,628

Serious

46,911

95% of reports

Hospitalization

17,132

Death reported

7,324

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective10,824
  • off label use8,671
  • rheumatoid arthritis6,004
  • fatigue5,699
  • pain5,648
  • arthralgia5,415
  • rash4,812
  • condition aggravated4,734
  • drug intolerance4,363
  • nausea4,239
  • headache4,231
  • systemic lupus erythematosus4,230
  • diarrhoea4,211
  • joint swelling4,179
  • treatment failure4,032

Reports by year received

View as table
YearReports
20048
200525
200610
200744
2008136
2009138
2010257
2011208
2012256
2013295
2014277
2015317
2016504
2017725
20181,254
20192,034
20202,716
20213,239
20224,585
20236,888
20248,971
20259,570
20267,171

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,531 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
systemic lupus erythematosusSignal4,23057.255.5206,060
rheumatoid arthritisSignal6,00423.623.0123,765
treatment failureSignal4,03221.621.075,755
drug intoleranceSignal4,36320.019.475,521
joint swellingSignal4,17915.214.753,663
condition aggravatedSignal4,7346.76.522,867
arthralgiaSignal5,4155.65.420,487
rashSignal4,8124.74.614,242
off label useSignal8,6714.24.122,081
painSignal5,6483.93.812,555
drug ineffectiveSignal10,8243.53.420,462
fatigueSignal5,6993.13.08,449
headacheSignal4,2312.92.85,286
diarrhoeaSignal4,2112.82.74,903
nauseaSignal4,2392.32.23,135

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.